跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AERMONY RESPICLICK - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
AERMONY RESPICLICK
Authorized
STANDARD
AERMONY RESPICLICK
teva canada limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
8cdccaed77bacca4
Company
teva canada limited
Type
Standard
Approval Details
Approval Id
8cdccaed77bacca4
Drug Approval Canada Name
AERMONY RESPICLICK
Product Name
AERMONY RESPICLICK
Status
Marketed
Status Date
2020-09-30
Original Market Date
2020-09-30
Din
02467895
Drug Class
Human
Dosage Form
Powder (Metered Dose)
Route Of Administration
Inhalation
Schedule
Prescription
Ahfs
68:04.00
Atc Original
R03BA05 FLUTICASONE
Atc Name
r 03 ba 05
Aig Number
0124685001
Company Name
teva canada limited
Company Address
30 Novopharm Court, Toronto, Ontario, Canada, M1B 2K9
Active Ingredients
FLUTICASONE PROPIONATE
55 MCG / ACT
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
8cdccaed77bacca4
Type
Standard
Back to Health Canada Approvals